Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury

Neuroscience Letters

Volumn 460, Issue 3, 2009, Pages 232-236

  Jawad, Noorulhuda ^a   Rizvi, Maleeha ^a   Gu, Jianteng ^a,b   Adeyi, Olar ^a   Tao, Guocai ^b   Maze, Mervyn ^a   Ma, Daqing ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Argon; Neuronal culture; Neuroprotection; Noble gas; Oxygen and glucose deprivation; Xenon

Indexed keywords

ARGON; GLUCOSE; HELIUM; INERT GAS; KRYPTON; NEON; OXYGEN; XENON;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; HYPOXIA; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARGON; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; CULTURE MEDIA; GLUCOSE; HELIUM; KRYPTON; MICE; MICE, INBRED BALB C; NEON; NEURONS; NEUROPROTECTIVE AGENTS; NOBLE GASES; OXYGEN;

EID: 67449164328     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.05.069     Document Type: Article

References (30)

1. Abraini J.H., Kriem B., Balon N., Rostain J.C., and Risso J.J. Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth. Analg. 96 (2003) 746-749
2. Bantel C., Maze M., and Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 110 (2009) 986-995
3. Choi D.W., Koh J.Y., and Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8 (1988) 185-196
4. Choi D.W., Maulucci-Gedde M., and Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7 (1987) 357-368
5. Coburn M. M., Maze M., and Franks N.P. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit. Care Med. 36 (2008) 588
6. Dähn S., Schwalbach P., Wöhleke F., Benner A., and Kuntz C. Influence of different gases used for laparoscopy (helium, carbon dioxide, room air, xenon) on tumor volume, proliferation, and apoptosis. Surg. Endosc. 17 (2003) 1653-1657
7. David H.N., Haelewyn B., Chazalviel L., Lecocq M., Degoulet M., Risso J.J., and Abraini J.H. Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J. Cereb. Blood Flow Metab. (2009) 1-7
8. David H.N., Haelewyn B., Rouillon C., Lecoq M., Chazalviel L., Apiou G., Risso J.J., Lemaire M., and Abraini J.H. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J. 22 (2008) 1275-1286
9. Dickinson R., Peterson B.K., Banks P., Simillis C., Martin J.C., Valenzuela C.A., Maze M., and Franks N.P. Competitive inhibition at the glycine site of the N-methyl-d-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 107 (2007) 756-767
10. Dingley J., Tooley J., Porter H., and Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37 (2006) 501-506
11. Franks N.P., Dickinson R., de Sousa S.L., Hall A.C., and Lieb W.R. How does xenon produce anaesthesia?. Nature 396 (1998) 324
12. Goto T., Nakata Y., and Morita S. Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia. Anesthesiology 98 (2003) 1-2
13. Harris P.D., and Barnes R. The uses of helium and xenon in current clinical practice. Anaesthesia 63 (2008) 284-293
14. Heinen A., Huhn R., Smeele K.M., Zuurbier C.J., Schlack W., Preckel B., Weber N.C., and Hollmann M.W. Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+)-sensitive potassium channel activation. Anesthesiology 109 (2008) 830-836
15. Homi H.M., Yokoo N., Ma D., Warner D.S., Franks N.P., Maze M., and Grocott H.P. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99 (2003) 876-881
16. Koblin D.D., Fang Z., Eger II E.I., Laster M.J., Gong D., Ionescu P., Halsey M.J., and Trudell J.R. Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics). Anesth. Analg. 87 (1998) 419-424
17. Ma D., Hossain M., Pettet G.K., Luo Y., Lim T., Akimov S., Sanders R.D., Franks N.P., and Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J. Cereb. Blood Flow Metab. 26 (2006) 199-208
18. Ma D., Lim T., Xu J., Tang H., Wan Y., Zhao H., Hossain M., Maxwell P.H., and Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J. Am. Soc. Nephrol. 20 (2009) 713-720
19. Ma D., Wilhelm S., Maze M., and Franks N.P. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br. J. Anaesth. 89 (2002) 739-746
20. Ma D., Yang H., Lynch J., Franks N.P., Maze M., and Grocott H.P. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98 (2003) 690-698
21. Pagel P.S., Krolikowski J.G., Shim Y.H., Venkatapuram S., Kersten J.R., Weihrauch D., Warltier D.C., and Pratt Jr. P.F. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth. Analg. 105 (2007) 562-569
22. Pan Y., Zhang H., VanDeripe D.R., Cruz-Flores S., and Panneton W.M. Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp. Neurol. 205 (2007) 587-590
23. Petzelt C., Blom P., Schmehl W., Muller J., and Kox W.J. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci. 72 (2003) 1909-1918
24. Preckel B., Weber N.C., Sanders R.D., Maze M., and Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 105 (2006) 187-197
25. Quillin M.L., Breyer W.A., Griswold I.J., and Matthews B.W. Size versus polarizability in protein-ligand interactions: binding of noble gases within engineered cavities in phage T4 lysozyme. J. Mol. Biol. 302 (2000) 955-977
26. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., and Guiba-Tziampiri O. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 1045 (2005) 22-30
27. Trudell J.R., Koblin D.D., and Eger 2nd E.I. A molecular description of how noble gases and nitrogen bind to a model site of anesthetic action. Anesth. Analg. 87 (1998) 411-418
28. Wilhelm S., Ma D., Maze M., and Franks N.P. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 96 (2002) 1485-1491
29. Xu J., Li C., Yin X.H., and Zhang G.Y. Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1-JNK cascade. Neuropharmacology 54 (2008) 1029-1040
30. Yarin Y.M., Amarjargal N., Fuchs J., Haupt H., Mazurek B., Morozova S.V., and Gross J. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res. 201 (2005) 1-9